125I粒子永久性组织间植入治疗颈部转移性恶性肿瘤10例

Ten cases of metastatic cervical cancer with the treatment of permanent 125I seeds interstitial implants

  • 摘要:
    目的 探讨125I粒子永久性组织间植入治疗颈部转移性恶性肿瘤的临床效果。
    方法 在B超引导下将125I粒子植入10例恶性肿瘤切除术后颈部淋巴结转移11处病灶肿瘤组织内,治疗1个月后观察疼痛缓解情况和瘤灶大小等变化并定期随访。
    结果 接受125I治疗的10例患者,随访6~14个月,均无不良反应发生。125I粒子植入1个月后,肿瘤病灶疼痛症状完全缓解2处,部分缓解9处;肿瘤病灶体积部分缓解10处,1处无改变。
    结论 125I粒子永久性组织间植入治疗颈部转移性恶性肿瘤是一种安全、微创、疗效好的方法。

     

    Abstract:
    Objective To investigate the clinical effect of permanent 125I seeds interstitial implants for metastatic cervical cancer.
    Methods Under the guidance of the B-sonography, 125I seeds were implanted into the eleven cervical lymph nodes of ten patients who had been given tumor resection.The pain relief and tumor size were observed in regular follow-up after one-month treatment.
    Results All the patients were followed up for 6-14 months, and the postoperative recovery was good with no complication.One month after the implantation, the pain symptom was alleviated entirely in two nodes and partly in nine nodes.The tumorsize shrank in ten nodes while there was no change in one node after one month.
    Conclusion Permanant 125I seeds interstitial implants for metastatic cervical cancer is a safe, minimally invasive and effective treatment.

     

/

返回文章
返回